by Baruch D. Kupperman, MD, PhD
Baruch D. Kupperman, MD, PhD, Professor and Chief of the Retina Service at the Gavin Herbert Eye Institute, University of California Department of Ophthalmology in Irvine, reviews data regarding efficacy and safety of the dexamethasone intravitreal implant plus laser vs that of laser monotherapy in patients with diffuse diabetic macular edema.
998 video views and 24,232 series views since 8/15/2011
-
Inherited Retinal Diseases
-
Thrombogenic Phase 3 Ocriplasmin Study
-
Achieving Water-tight Sclerotomies after 23G Surgery
-
PACORES Update
-
Sclerally-fixated IOLs Without Sutures
-
Does Suturing 23-Gauge Sclerotomies Reduce Postop Vitreous Hemorrhage in Di…
-
Modified Probe for Small-gauge Vitrectomy
-
The Role of Scissors in Diabetic Traction Retinal Detachment Surgery
-
Fine Needle Aspiration Biopsy
-
Adjunctive Steroids for Small-gauge Vitrectomy
-
COPERNICUS
-
Ranibizumab Variable Dosing: Horizon Extension Data
-
Dexamethasone Implant Plus Laser vs Laser Monotherapy
-
Ocriplasmin Phase 3 Data
-
Pneumatic Retinopexy, Pars Plana Vitrectomy, and Scleral Buckling
-
FAME Subanalyses
-
DA VINCI
-
Allen Ho, MD, Reviews Highlights of Upcoming Retina Meeting
-
Dean Eliott, MD, Reviews Highlights of Upcoming Retina Meeting
